Navigation Links
Rutgers University launches neuroscience consortium
Date:7/8/2013

hold as scientists who may not have worked together previously become Rutgers colleagues.

And with President Obama calling for a multibillion-dollar plan to map the human brain to understand its complexities and unlock the mysteries of debilitating neurodegenerative diseases, many neuroscientists say Rutgers is positioning itself to be a university at the forefront of such research.

Building a Bridge

This is a good start, say those involved with the development of the new consortium. But too much information critical to discovering preventive treatments and possible cures is still falling under the radar of many who could benefit from the data, says Marco Zarbin, professor and chair of the Department of Ophthalmology and Visual Science at New Jersey Medical School in Newark. Zarbin has done research to develop treatments for retinal eye disease through cell transplantation.

"We end up in our own little silos," says Zarbin, a member of the consortium, who insists that scientists and physicians have become so specialized that fewer collaborations necessary for big scientific discoveries are occurring. "The great thing now about the new Rutgers is that intellectually we have all the different skills needed to do big things in both science and medicine."

Moving forward, Suhayl Dhib-Jalbut, professor and chair of the Department of Neurology at Robert Wood Johnson Medical School, says a virtual neuroscience institute needs to be created to connect the neuroscience programs at Rutgers to its medical schools and make access to information seamless. This means developing a robust website through which information about both the work being done at the university and critical funding mechanisms for neuroscience research could be easily accessed by researchers, faculty, and students.

"What we have to do is bring basic science and clinical trials together by creating a structure that allows us to get this done so
'/>"/>

Contact: Robin Lally
rlally@ur.rutgers.edu
732-932-7084 x652
Rutgers University
Source:Eurekalert

Page: 1 2 3 4 5

Related medicine news :

1. Rutgers-Camden professor examines social capabilities of performing multiple-action sequences
2. Phone app for managing heart disease created by Rutgers-Camden nursing student
3. Rutgers neuroscientist sheds light on cause for chemo brain
4. Rutgers professor recognized for revolutionizing agriculture
5. President Obama selects Rutgers cell biologist Nihal Altan-Bonnet to receive prestigious award
6. Rutgers study: Anxiety disorders in poor moms likely to result from poverty, not mental illness
7. Rutgers leads effort to replicate care management programs in 4 U.S. cities
8. Children with asthma marginalized in movies, says Rutgers-Camden researcher
9. Rutgers team discovers novel approach to stimulate immune cells
10. Race apparently a factor in sleep apnea, Wayne State University researcher finds
11. University of New England and Partners Celebrate Opening of Portland Community Health Center at Riverton June 20 for Underserved Populations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... (PRWEB) , ... September 04, 2015 , ... ... a line of personal humidifying medical devices, announced its only mission and research ... Bio-Logic Aqua® Research Founder Sharon Kleyne, body water evaporation is becoming dangerously accelerated. ...
(Date:9/4/2015)... ... September 04, 2015 , ... The conference program for ... Florida October 9-10, 2015 at the Diplomat Resort & Spa has been announced ... and researchers at the top of their field and will be presenting sessions ...
(Date:9/4/2015)... ... 04, 2015 , ... ECC announces the site selection and ... adults with intellectual, developmental and acquired disabilities. The first community, named Luna Azul, ... “pocket” homes. In this community, adults will live safely and permanently in homes ...
(Date:9/4/2015)... ... 04, 2015 , ... Steven Winter Associates, Inc., (SWA) is ... selected for the Residential Award of Merit by the Connecticut Green Building Council ... a highly competitive field of submissions, the net-zero energy residence will be honored ...
(Date:9/4/2015)... ... , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has written an open ... upcoming trip to the United States. , Yisrayl lays out what he says is the ... society is. Yisrayl also provides the meaning of his own name and describes what bible ...
Breaking Medicine News(10 mins):Health News:Bio-Logic Aqua® Research Announces Water Life Science and Body Water Evaporation as Research Focus and Mission 2Health News:Bio-Logic Aqua® Research Announces Water Life Science and Body Water Evaporation as Research Focus and Mission 3Health News:Integrative Healthcare Symposium Focus On: The Microbiome Conference Program Announced 2Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 2Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 3Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 4Health News:South Glastonbury Home Selected for Award by Connecticut Green Building Council 2Health News:Yisrayl Hawkins Writes Open Letter to Pope Francis In Light of Approaching U.S. Visit 2
... statement issued today, the nonpartisan watchdog group Public Campaign Action ... opposing health care reform as "hazardous to America,s health, and ... of working families and small business owners in Kentucky." , ... cited Sen. McConnell,s opposition to health care legislation that includes ...
... (NYSE: DGX ), the world,s leading provider of ... to speak at the William Blair & Company 29th Annual ... The Quest Diagnostics presentation is scheduled to begin at ... conference, the company will reaffirm its 2009 guidance for revenue ...
... June 8 The below listed groups issued the ... Committee Meeting on June 9-10: , , As ... urge the FDA to carefully consider the importance of ... pediatric and adolescent populations. Access to safe and ...
... Women continue to be under-enrolled in cancer clinical trials, according ... issue of CANCER , a peer-reviewed journal of the ... are needed to ensure that oncologists know the true effects ... 1993, the National Institutes of Health called for clinical trials ...
... 8 ViroPharma Incorporated (Nasdaq: VPHM ) today ... board of directors. , , Dr. Baldino brings several ... to ViroPharma. He is the chief executive officer and ... international biopharmaceutical company in Chester County, Pennsylvania. Dr. Baldino ...
... , Weight Loss Leader Now Offers A Proven Solution to ... , HORSHAM, Pa., June 8 Nutrisystem, Inc. (Nasdaq: ... announced today that it will now be offering its Nutrisystem Works(TM) ... to help employers take control of rising health care costs. ...
Cached Medicine News:Health News:Watchdog Group Blasts McConnell for Putting Insurance Donors Before Health Care Reform 2Health News:Quest Diagnostics to Speak at the William Blair & Company 29th Annual Growth Stock Conference 2Health News:Joint Statement on Atypical Antipsychotic Use in Children 2Health News:Joint Statement on Atypical Antipsychotic Use in Children 3Health News:Women underrepresented in most cancer research 2Health News:ViroPharma Announces Appointment of Frank Baldino, Jr., Ph.D. to Board of Directors 2Health News:ViroPharma Announces Appointment of Frank Baldino, Jr., Ph.D. to Board of Directors 3Health News:New Nutrisystem Works(TM) Offers Corporate America New Weapon in the Fight Against Obesity 2Health News:New Nutrisystem Works(TM) Offers Corporate America New Weapon in the Fight Against Obesity 3Health News:New Nutrisystem Works(TM) Offers Corporate America New Weapon in the Fight Against Obesity 4
(Date:9/4/2015)... Physician E-sampling is becoming well established across ... key marketing sales tactic in recent years. However, some ... a supplement to traditional sampling. According ... E-sampling has been seeded across multiple therapeutic areas- including ... has been in place for five or more years ...
(Date:9/4/2015)... 2015  Janssen Research & Development, LLC (Janssen) ... (FDA) has accepted for Priority Review the Biologics ... for patients with multiple myeloma who are refractory ... immunomodulatory agent (IMiD), or who have received three ... PI and an IMiD. This is referred to ...
(Date:9/4/2015)... , Sept. 4, 2015 Fair Rate Funding, ... Jersey , reports a dramatic increase in lawsuit filings ... of filed Xarelto lawsuits in the Philadelphia ... to over 300 cases.  In the Louisiana ... for the Eastern District of Louisiana , ...
Breaking Medicine Technology:Current and Future Trends in Physician E-Sampling Programs for the Pharmaceutical Industry 2U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 2U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 3U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 4U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 5U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 6U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 7Xarelto Lawsuit Funding Firm, Fair Rate Funding Reports a Steady Rise in Xarelto Product Liability Lawsuit Filings 2Xarelto Lawsuit Funding Firm, Fair Rate Funding Reports a Steady Rise in Xarelto Product Liability Lawsuit Filings 3
... Safety and Pharmacokinetic Results in Healthy Volunteers to be Presented at ... ... (Nasdaq: ANDS ) announced today preliminary results of a Phase I,clinical trial ... trial of ANA598 in patients chronically infected,with hepatitis C virus (HCV). In the ...
... Rehovot, Israel, reported today results of its internal,clinical trial of ... cancer., In the trial a total of 76 sputum ... Healthy individuals that never smoked 2. Heavy smokers with ... cancer patients (Stage 1) 4. Advanced stage lung cancer ...
Cached Medicine Technology:Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients 2Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients 3Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients 4Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients 5Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients 6BioView Reports Interim Results of Early Detection Lung Cancer Diagnostic Test 2
16mm Slightly Curved sharp Tips; overall length 120mm; Stainless Steel...
9mm Curved Blades with Sharp Pointed Tips; overall length 90mm; Stainless Steel....
3 Gently Curved Prongs, 5mm extended, Stainless Steel Tips; with titanium handle....
Straight shafts with fine Pierse type tips on a 5mm platform; In Titanium...
Medicine Products: